BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 28404599)

  • 1. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.
    Tran TQ; Lowman XH; Kong M
    Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
    Morrison AJ
    FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and epigenetics: a link cancer cells exploit.
    Carrer A; Wellen KE
    Curr Opin Biotechnol; 2015 Aug; 34():23-9. PubMed ID: 25461508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Signaling to the Nucleus in Cancer.
    Campbell SL; Wellen KE
    Mol Cell; 2018 Aug; 71(3):398-408. PubMed ID: 30075141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Signaling into Chromatin Modifications in the Regulation of Gene Expression.
    Gao T; Díaz-Hirashi Z; Verdeguer F
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chromatin epigenetic modifications in cancer generation].
    Arenas-Huertero F; Recillas-Targa F
    Gac Med Mex; 2002; 138(6):547-55. PubMed ID: 12532619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer.
    Nordgren KK; Skildum AJ
    Eur J Clin Invest; 2015 Jan; 45 Suppl 1():9-15. PubMed ID: 25524581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone modifications--epigenetics in cancer.
    Waldmann T; Schneider R
    Curr Opin Cell Biol; 2013 Apr; 25(2):184-9. PubMed ID: 23347561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic interplay between histone modifications and DNA methylation in gene silencing.
    Vaissière T; Sawan C; Herceg Z
    Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming and epigenetic modifications on the path to cancer.
    Sun L; Zhang H; Gao P
    Protein Cell; 2022 Dec; 13(12):877-919. PubMed ID: 34050894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of epigenetic mechanisms in cancer.
    Maleszewska M; Wojtas B; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
    D'Alessio AC; Szyf M
    Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.